As anxiety mounts over climate change, seven of the world’s largest drugmakers urged dozens of their suppliers to outline targets they expect them to reach over the next few years in order to reduce carbon footprints.
In explaining their action, the companies — GSK, Sanofi, Roche, AstraZeneca, Novo Nordisk, Samsung Biologics, and Merck KGaA — noted that the health care sector contributes approximately 5% of global greenhouse gas emissions, with around half of this coming from healthcare supply chains.
“Joint action at scale is needed to move the needle,” they wrote in a statement. “…Healthcare supply chains must become greener, more efficient and circular. We must work across the value chain to decarbonize operations and do all we can to move away from fossil-fueled heat and power… Shifting to net zero, climate-resilient health systems cannot be achieved in siloes.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect